Drug Shortage Report for TEVA-PROGESTERONE

Last updated on 2021-02-11 History
Report ID 130288
Drug Identification Number 02439913
Brand name TEVA-PROGESTERONE
Common or Proper name PROGESTERONE 100MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PROGESTERONE
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size PP 30
ATC code G03DA
ATC description PROGESTOGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-16
Estimated end date 2021-02-28
Actual end date 2021-02-10
Shortage status Resolved
Updated date 2021-02-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-02-11 French Compare
v5 2021-02-11 English Compare
v4 2021-01-14 French Compare
v3 2021-01-14 English Compare
v2 2020-12-17 French Compare
v1 2020-12-17 English Compare